Repurposing medicinal compounds for blood cancer treatment

por McCabe, Bronagh, Liberante, Fabio, Mills, Ken I.
Publicado 2015

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia

por Young, Christine S., Clarke, Kathryn M., Mills, Ken I.
Publicado 2015

The Impact of Epigenetic Modifications in Myeloid Malignancies

por Venney, Deirdra, Mohd-Sarip, Adone, Mills, Ken I
Publicado 2021

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy

por Lappin, Katrina M., Mills, Ken I., Lappin, Terence R.
Publicado 2021

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer

por Khan, Ghazala, Brooks, Suzanne E, Mills, Ken I, Guinn, Barbara-Ann
Publicado 2015

Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia

por Davis, Lindsay, Mills, Ken I., Orchard, Kim H., Guinn, Barbara-Ann
Publicado 2020

Significance of NPM1 Gene Mutations in AML

por Hindley, Andrew, Catherwood, Mark Alexander, McMullin, Mary Frances, Mills, Ken I.
Publicado 2021

Identification of Gene Networks Associated with Acute Myeloid Leukemia by Comparative Molecular Methylation and Expression Profiling

por Dellett, Margaret, O’Hagan, Kathleen Ann, Colyer, Hilary Ann Alexandra, Mills, Ken I.
Publicado 2010

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy

por Young, Christine S., Clarke, Kathryn M., Kettyle, Laura M., Thompson, Alexander, Mills, Ken I.
Publicado 2017

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia

por Guinn, Barbara-ann, Mohamedali, Azim, Mills, Ken I., Czepulkowski, Barbara, Schmitt, Michael, Greiner, Jochen
Publicado 2007

A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia

por Lappin, Katrina M., Davis, Lindsay, Matchett, Kyle B., Ge, Yubin, Mills, Ken I., Blayney, Jaine K.
Publicado 2020

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia

por Cairns, Lauren V., Lappin, Katrina M., Mutch, Alexander, Ali, Ahlam, Matchett, Kyle B., Mills, Ken I.
Publicado 2021

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics

por Ali, Ahlam A., Cairns, Lauren V., Clarke, Kathryn M., Blayney, Jaine K., Lappin, Katrina M., Mills, Ken I.
Publicado 2023

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy

por Hay, Jodie F., Lappin, Katrina, Liberante, Fabio, Kettyle, Laura M., Matchett, Kyle B., Thompson, Alexander, Mills, Ken I.
Publicado 2017

Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients

por Greiner, Jochen, Brown, Elliott, Bullinger, Lars, Hills, Robert K., Morris, Vanessa, Döhner, Hartmut, Mills, Ken I., Guinn, Barbara-ann
Publicado 2021

GATA2 regulates the erythropoietin receptor in t(12;21) ALL

por Gaine, Marie E., Sharpe, Daniel J., Smith, James S., Colyer, Hilary A.A., Hodges, Vivien M., Lappin, Terry R., Mills, Ken I.
Publicado 2017

A molecular signature of dormancy in CD34(+)CD38(-) acute myeloid leukaemia cells

por Al-Asadi, Mazin Gh., Brindle, Grace, Castellanos, Marcos, May, Sean T., Mills, Ken I., Russell, Nigel H., Seedhouse, Claire H., Pallis, Monica
Publicado 2017

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia

por Jordaens, Stephanie, Cooksey, Leah, Freire Boullosa, Laurie, Van Tendeloo, Viggo, Smits, Evelien, Mills, Ken I., Orchard, Kim H., Guinn, Barbara-ann
Publicado 2020

Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn’s-like Lymphoid Reaction

por Boncheva, Viktoriya B., Linnebacher, Michael, Kdimati, Said, Draper, Hannah, Orchard, Laurence, Mills, Ken I., O’Sullivan, Gerald, Tangney, Mark, Guinn, Barbara-ann
Publicado 2022

Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML

por Smith, James S., Lappin, Katrina M., Craig, Stephanie G., Liberante, Fabio G., Crean, Clare M., McDade, Simon S., Thompson, Alexander, Mills, Ken I., Savage, Kienan I.
Publicado 2020